Teicoplanin use and emergence of Staphylococcus haemolyticus: Is there a link? [1]

Clinical Microbiology and Infection

Volumn 12, Issue 1, 2006, Pages 96-97

  Falcone, M ^a   Giannella, M ^a   Raponi, G ^a   Mancini, C ^a   Venditti, Mario ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CEPHALOSPORIN DERIVATIVE; METICILLIN; POLYPEPTIDE ANTIBIOTIC AGENT; TEICOPLANIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; BACTEREMIA; BACTERIUM ISOLATION; BLOOD CULTURE; COAGULASE NEGATIVE STAPHYLOCOCCUS; DRUG EFFICACY; DRUG SAFETY; DRUG USE; HEMATOLOGIC MALIGNANCY; HOSPITAL INFECTION; HUMAN; LETTER; MINIMUM INHIBITORY CONCENTRATION; ORTHOPEDIC SURGERY; PATIENT MONITORING; POSTOPERATIVE INFECTION; PRIORITY JOURNAL; STAPHYLOCOCCUS HAEMOLYTICUS; TREATMENT OUTCOME; VASCULAR SURGERY;

STAPHYLOCOCCUS HAEMOLYTICUS;

EID: 33644870733     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1111/j.1469-0691.2005.01307.x     Document Type: Letter

References (5)

1. Vardakas KZ, Soteriades ES, Chrysanthopoulou SA et al. Perioperative anti-infective prophylaxis with teicoplanin compared to cephalosporins in orthopaedic and vascular surgery involving prosthetic material. Clin Microbiol Infect 2005; 11: 775-777.
2. Santos Sanches I, Mato R, de Lancastre H et al. Patterns of multidrug resistance among methicillin-resistant hospital isolates of coagulase-positive and coagulase-negative staphylococci collected in the international multicenter study RESIST in 1997 and 1998. Microb Drug Resist 2000; 6: 199-211.
3. Baiocchi P, Capone A, Carfagna P, Santini C, Venditti M. Changes in susceptibilities to teicoplanin, vancomycin and other antibiotics among Staphylococcus aureus isolates in a tertiary-care university hospital. Int J Antimicrob Agents 1996; 7: 93-96.
4. Falcone M, Micozzi A, Pompeo ME et al. Methicillin-resistant staphylococcal bacteremia in patients with hematologic malignancies: clinical and microbiological retrospective comparative analysis of Staphylococcus haemolyticus, Staphylococcus epidermidis and Staphylococcus aureus. J Chemother 2004; 16: 540-548.
5. Raponi G, Ghezzi MC, Ghepardi G et al. Antimicrobial susceptibility, biochemical and genetic profiles of Staphylococcus haemolyticus strains isolated from the bloodstream of patients hospitalized in critical care units. J Chemother 2005; 17: 264-269.